Despite the impacts of genetic, familial, and environmental risk factors on type 2 DM occurrence, it is known that DM in acromegaly develops as a result of the effects of GH and IGF-1 excess on the pancreatic β-cell function, insulin sensitivity, and gluconeogenesis [7]. This evidence concerns the gene GH1 and acromegaly.